Insights

Type Clear all

Select all that apply

Topic Clear all

Select all that apply

Reset filters

icons/content-types/article article

CMC Best Practices: Expediting Orphan Drug Development to Combat Rare Disease

February 28 marks the global observance of Rare Disease Day, a day when we participate in raising awareness and generating change for the global population and their families living with rare diseases.

icons/content-types/fact sheet fact sheet

Comprehensive mRNA Solutions

Partner with Curia for combined expertise, speed and reliability to support the research, development and manufacturing of your mRNA product.

icons/content-types/infographic infographic

Curia's Recently Filed DMFs

We offer a robust portfolio of market-leading APIs and world-class capabilities in niche and high-barrier-to-entry technologies.

icons/content-types/article article

The M.O. Behind Choosing a CDMO: Three Considerations for New Drug Developers

For many who are new to drug development, the greatest challenge is not necessarily discovering a blockbuster molecule—it’s finding a team capable of carrying that molecule through the complexities that lie between the research lab and the patien...

icons/utility/left caret 1 icons/utility/right caret